Clinigen Group (CLIGF) Lifted to “Hold” at Zacks Investment Research
According to Zacks, “Clinigen Group plc is a pharmaceutical and services company. Its business focuses in areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Clinigen Group plc is headquartered in Burton-on-Trent, the United Kingdom. “
OTCMKTS:CLIGF opened at $9.87 on Tuesday. Clinigen Group has a 1 year low of $9.87 and a 1 year high of $12.59.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Clinigen Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group and related companies with MarketBeat.com's FREE daily email newsletter.